Argentina - espanhol - ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica)

bayer s.a. - nifedipina - capsulas blandas - nifedipina 10 mg

Argentina - espanhol - ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica)

boehringer ingelheim s.a. - tripanavir - capsulas blandas - tripanavir 250 mg

Espanha - espanhol - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sandoz farmaceutica, s.a. - acidos omega 3 esteres etilicos - excipientes: glicerol,capsulas de gelatina blanda - agentes modificadores de los lÍpidos, monofÁrmacos - otros agentes modificadores de los lípidos - triglicéridos omega-3, incluidos otros ésteres y ácidos

Espanha - espanhol - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

mylan ire healthcare limited - lipasa; amilasa; proteasa - granulado gastrorresistente - 5.000 u/3.600 u/200 u - lipasa 5000 u; amilasa 3600 u; proteasa 200 u - multienzimas (lipasa, proteasa, etc.)

Venezuela - espanhol - Instituto Nacional de Higiene

msd farmaceutica, c.a. - testosterona - c - 40 mg (a3)

Venezuela - espanhol - Instituto Nacional de Higiene

novartis de venezuela, s.a. - tribenosido - c - 400 mg

Peru - espanhol - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

mega labs latam s.a. - capsula blanda - por ; acetato de alfa tocoferol 200.000000 mg; ascorbato de calcio dihidrato 302.578000 mg; levadura con selenio 50.000000 mg; citrato de zinc 24.026000 mg; - multivitamínicos con otros minerales, incl. combinaciones

Peru - espanhol - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

productos roche q.f.s.a. - capsula - por ; calcitriol 0.500000 mcg; - calcitriol

Peru - espanhol - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

productos roche q.f.s.a. - capsula - por ; calcitriol 0.250000 mcg; - calcitriol

União Europeia - espanhol - EMA (European Medicines Agency)

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.